Leaders of organizations that fund vision research convene in Washington, D.C. to increase collaboration and maximize the impact of research funding for sight-threatening diseases.
The recipient of the Research to Prevent Blindness / David Epstein Career Advancement Award in Glaucoma Research sponsored by Alcon is Alex Huang, MD, PhD, Associate Professor of Ophthalmology at the UC San Diego School of Medicine.
The American Academy of Ophthalmology and Research to Prevent Blindness announced the 2023 recipients of the RPB/AAO Award for IRIS Registry Research. The researchers will use the IRIS Registry—the nation’s largest comprehensive eye disease clinical registry—to conduct population-based studies in ophthalmology and blindness prevention.
Patricia Ann D’Amore, PhD, MBA, has been selected as the 2024 RPB David F. Weeks Award for Outstanding Vision Research (Weeks Award). Dr. D’Amore will receive her award and deliver a presentation during the AUPO 2024 Annual Meeting in Austin, Texas in February.
Research to Prevent Blindness (RPB) announces two new grants to support high-impact vision research. The new grants are the: RPB / Tom Wertheimer Career Development Award in Data Science and RPB / Mary Tyler Moore Vision Initiative Physician-Scientist Award.
Today, Research to Prevent Blindness (RPB) and more than 30 other organizations are convening in Washington DC for the Vision Research Funding Partnership event, which was organized around the theme of “The Research Pipeline – From Premise to Patient.”
Research to Prevent Blindness announces a new round of awardees who are generating critical knowledge around a host of sight-threatening conditions. With this latest round of funding, RPB has provided more than $400 million in research funding.
David J. Calkins, PhD, has been selected as the 2023 RPB David F. Weeks Award for Outstanding Vision Research.
Award recipients to use the American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight) clinical database to improve care for all patients
Research to Prevent Blindness and Castle Biosciences today announced that they are partnering to increase opportunities for medical students to gain research experiences, specifically in the field of ocular cancer.
Research to Prevent Blindness and Aerie Pharmaceuticals are partnering to provide grant opportunities to support novel research in glaucoma.
Research to Prevent Blindness and the American Osteopathic Colleges of Ophthalmology & Otolaryngology-Head and Neck Surgery Foundation announce a new multi-year partnership to provide opportunities for students of osteopathic medicine to gain research experiences in vision science.
Research to Prevent Blindness (RPB) is pleased to open a new round of grant funding, up to $4.7 million, for high-impact vision research. With a focus on scientific excellence, RPB funds grants into research across all sight-threatening conditions.
The American Academy of Ophthalmology and Research to Prevent Blindness (RPB) today announced the recipients of the Research to Prevent Blindness/American Academy of Ophthalmology Award for IRIS® Registry Research.
Donald Zack, MD, PhD, is recognized for ground-breaking contributions to the field of vision research, funded by Research to Prevent Blindness, an anonymous donor, and the Association of University Professors of Ophthalmology.
Research to Prevent Blindness and The Glaucoma Foundation are pleased to announce a new round of grants, the Career Advancement Awards (CAAs), that support early-career researchers as they seek new knowledge related to eye diseases.
The Glaucoma Foundation (TGF) and Research to Prevent Blindness (RPB) have partnered to launch a new grant aimed at supporting under-represented racial and ethnic minority researchers in the pursuit of glaucoma research. The TGF (sponsored by Patricia Hill) / RPB Fellowships in Glaucoma provide one-year, $10,000 fellowships focused on substantive glaucoma research.
David Williams, PhD, has been selected as the 2021 RPB David F. Weeks Award for Outstanding Vision Research. The Weeks Award, funded through the generosity of Research to Prevent Blindness, an anonymous donor, and the Association of University Professors of Ophthalmology, annually recognizes and celebrates an excellent vision researcher.
Research to Prevent Blindness announces exciting changes to its flagship grant, the RPB Career Development Award, by increasing both the amount of funding and the number of awards funded.
Research to Prevent Blindness and the Allergan Foundation announce new grants to increase funding for innovative research from early-career vision scientists.
Research to Prevent Blindness (RPB) celebrates the 60th anniversary of its incorporation. Watch the new video about its many sight-saving accomplishments over the past six decades.
Research to Prevent Blindness (RPB) is pleased to announce that RPB Stein Innovation Awardee Gregg Semenza, MD, PhD, at Johns Hopkins University School of Medicine, has been named a winner of the 2019 Nobel Prize in Medicine.
Christine Curcio, PhD, has been selected as the 2019 RPB David F. Weeks Award for Outstanding AMD Research (Weeks Award). The Weeks Award, funded through the generosity of Research to Prevent Blindness (RPB), an anonymous donor, and the Association of University Professors of Ophthalmology (AUPO), annually recognizes and celebrates an excellent researcher focused on age-related macular degeneration (AMD).
The American Academy of Ophthalmology and Research to Prevent Blindness today announced this year’s recipients of the RPB/AAO Award for IRIS® Registry Research, who are conducting big data research in ophthalmology and blindness prevention.
Today, the vision community and its coalition partners announced awareness and educational activities in July 2019 around the annual recognition of Dry Eye Awareness Month.
Research to Prevent Blindness, with its partners, the American Macular Degeneration Foundation (AMDF) and the International Retinal Research Foundation (IRRF), has awarded four grants aimed at stimulating and supporting new lines of research targeting age-related macular degeneration (AMD).
Research to Prevent Blindness (RPB) announces the 30th anniversary of one of its flagship grant programs: the RPB Career Development Award (CDA).
Research to Prevent Blindness (RPB) and Lions Club International Foundation (LCIF) announced today that they will continue their partnership in the RPB/LCIF Low Vision Research Award.
Jayakrishna Ambati, MD, has been selected as the 2018 RPB David F. Weeks Award for Outstanding AMD Research (Weeks Award).
The American Academy of Ophthalmology and Research to Prevent Blindness today announced the first recipients of the RPB/AAO Award for IRIS® Registry Research. The grant supports researchers who want to conduct population-based studies in ophthalmology and blindness prevention.
The vision community and its coalition partners refocus education and communications in 2018 around July as Dry Eye Awareness Month. Following the landmark publication of the Tear Film & Ocular Surface Society’s Dry Eye Workshop II, dry eye experts return to Congress and expound upon the Report’s impact in clinical practice and research.
Research to Prevent Blindness has opened a new round of grants available to researchers across the country. This new round of grants significantly expands the pool of applicants who are eligible, by making a number of individual researcher awards available to researchers at all U.S. academic medical centers.
Research to Prevent Blindness and the American Academy of Ophthalmology today announced that they have created a new category of grant to support researchers who want to use the Academy’s IRIS® Registry database to conduct population-based studies in ophthalmology and blindness prevention.
Research to Prevent Blindness-supported researchers in New York (at Columbia University and University of Rochester) made a critical discovery about the gene mutation that causes many retinal degenerative diseases, opening the door for a new line of research into potential treatments.
Researchers at Columbia University Medical Center utilized their Research to Prevent Blindness (RPB) grants to make progress in characterizing the genetic and physiologic components of Usher syndrome—the most common cause of deaf-blindness.
On May 4th, RPB-supported researchers at Washington University School of Medicine in St. Louis published a study identifying a biomarker that could help to predict glaucoma damage before vision loss.
Scientists at the Wayne State University School of Medicine Department of Ophthalmology at the Kresge Eye Institute have shown that the Zika virus can replicate in the eye’s retinal cells, causing severe tissue damage and even blindness. The research is supported in part by Research to Prevent Blindness.
RPB-supported vision researchers at Washington University School of Medicine in St. Louis have contributed key data to a new study that identifies a natural compound that slows typical signs of aging in mice. The study, published today in Cell Metabolism, shows that older mice drinking water supplemented with NMN (nicotinamide mononucleotide) resembled younger mice in measures of metabolism and energy production.
A common pathway involved in photoreceptor death has been identified in retinitis pigmentosa, advanced dry age-related macular degeneration and other retinal diseases, with early evidence of a possible halt to vision loss related to treatment of the pathway.
"Vision impairment remains notably absent from many population health agendas and community programs,” say the authors of a new report, "Making Eye Health a Population Health Imperative: Vision for Tomorrow," from The National Academies of Sciences, Engineering, and Medicine.
Researchers at Washington University School of Medicine in St. Louis published a study that shows that genetic material from the Zika virus has been found in tears. The study, fast-tracked for publication in Cell Reports, was conducted in mice, thereby creating an animal model for studying transmission and treatment of this alarming virus. The study, published September 6, 2016, also confirms that the Zika virus can lead to cell death in the eyes. Research to Prevent Blindness, located in New York, provided funding for this study.
The $1.4 million, two-pronged initiative involves funding partnerships with Lions Clubs International Foundation (LCIF), Reader’s Digest Partners for Sight Foundation (RDPFS), and our newest partner, Consumer Technology Association™ Foundation (CTAF).
Separate awards will fund research on the brain's roll in a compromised visual system and on technology to make daily tasks easier for those with vision loss.
RPB President Brian F. Hofland will present an overview of investigations conducted by leaders in the fields of retinal imaging, early disease detection, and photoreceptor regeneration and transplantation. The RPB featured scientists will be present for Q&A.
As medical professionals search for new ways to personalize diagnosis and treatment of disease, RPB-supported researchers at the University of Iowa have already put into practice what may be the next big step in precision medicine: personalized proteomics.
Researchers believe that adults whose eyes are slow to adjust to the dark have a greater risk of developing age-related macular degeneration.
RPB-supported researchers have made a significant discovery that might lead to the delay or prevention of the most common cause of blindness in the elderly: age-related macular degeneration (AMD). Patients who take the drug L-DOPA (for Parkinson Disease, Restless Legs or other movement disorders) are significantly less likely to develop AMD and, if they do, it is at a significantly later age.
"It's not everyday that one newly discovers parts of the human body," says Roy S. Chuck, MD, PhD, Chairman Department of Ophthalmology and Visual Sciences, Albert Einstein College of Medicine.
$1.2 million initiative will ask leading scientists to address complex aspects of degraded visual processing with the goal of expanding key knowledge, developing new treatment approaches, and generating technology solutions to enhance vision for those with some remaining sight.
The Research to Prevent Blindness Mildred Krahmer Sanders and William Clifford Sanders Laboratory for Vision Research opened for investigations at the University of Florida, Gainesville, following a national competition to house the facility.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right